Our NAV-005 antagonist binds the immunosuppressive HIO-1 factor and blocks its ability to suppress mAb, TCE and ADC ...
In a recent study published in the journal Nature, a research team consisting of scientists from the National Institutes of Health and Stanford University investigated how the skin independently ...